Caplin Point Laboratories Share Price

Small Cap | Pharmaceuticals and health care | NSE: CAPLIPOINT | BSE: 524742

₹2,022.90 image-27.55 (-1.34 %)

Last Updated: 21 Feb 2025 04:01 PM

Technicalsimage BEARISHimage

Overview

Open (₹) 2,071.90

High (₹) 2,099.15

Low (₹) 2,021.95

Prev. Close (₹) 2,050.45

Volume 5,696

VWAP (₹) 2,059.16

ROCE (%) 23.86

Industry P/E 43.99

TTM P/E 29.84

P/B Ratio 6.78

Market Cap (₹) Cr.15,429.23

Dividend Yield (%)0.25

EPS (₹) 59.90

ROE20.02%

Sales Growth (%) 15.5

Profit Growth (%)22.4

Day Range

2,099.152,099.15

L
H

52 Week Range

1,221.002,636.00

L
H

Historical Returns

Returns (6M)

9.82 %

Returns (1Y)

35.11 %

Returns (3Y)

178.58 %

Returns (5Y)

546.6 %

Returns (6M)

9.82 %

Returns (1Y)

35.11 %

Returns (3Y)

178.58 %

Returns (5Y)

546.6 %

SWOT Analysis

  • Effectively using its capital to generate profits - ROCE improved in the last year
  • Company with (21.80%) TTM EPS Growth
  • Company with no debt
  • Book value per share improving over the last 2 years
  • Company with 21.80% positive TTM EPS growth
  • Increasing Annual Revenue for Past 2 Years
  • Strong long-term momentum: Price above long-term moving averages (EMA_200)
  • Bullish MACD crossover (12,6,9) indicates potential upward price movement.

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 49.96

MFI 52.61

ATR 106.34

Commodity Channel Index 2.95

ROC125 16.33

ROC21 -5.12

Williams %R -62.58

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current2,078.852,127.602,156.052,050.402,001.651,973.201,924.45
Week Ago2,008.792,101.922,159.891,950.821,857.691,799.721,706.59
Month Ago2,225.092,256.722,276.442,205.372,173.742,154.022,122.39

EMA & SMA
info_icon

2022.90

Current Price

EMA & SMApin

Bullish Moving Averages

7

Bearish Moving Averages

13

5 Day 1996.61


9 Day 2011.17


10 Day 2036.10


12 Day 2077.95


14 Day 2067.59

20 Day 2035.16


26 Day 2080.40


50 Day 2248.55


100 Day 2129.02


200 Day 1849.29

Deals & Announcements

Bulk and Block Deals

No bulk or block deals available.

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
24 Mar, 2023P VijayalakshmiAcquisition₹609.008,98,790BSE
24 Nov, 2021Sathish KrishnanDisposal₹811.5125,000BSE
24 Nov, 2021Arulsudar NatrajanDisposal₹831.001,500BSE
24 Nov, 2021Arulsudar NatrajanDisposal₹832.002,000BSE
19 Nov, 2021Arulsudar NatrajanDisposal₹866.051,500BSE
19 Nov, 2021Subramanian NarayanaswamyDisposal₹870.00100BSE
19 Nov, 2021Subramanian NarayanswamyDisposal₹867.754,900BSE
08 Nov, 2021Sachin Dondiram PatilAcquisition₹2.005,000BSE
08 Nov, 2021Rubavanan CAcquisition₹2.001,667BSE
08 Nov, 2021Venkataraju M PAcquisition₹2.002,500BSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
07 Aug, 2024Rs.2.5000 per share(125%)Final Dividend23 Sept, 202401 Jan, 1970
16 May, 2024Rs.2.5000 per share(125%)Interim Dividend31 May, 202431 May, 2024
07 Aug, 2023Rs.2.5000 per share(125%)Final Dividend14 Sept, 202301 Jan, 1970

Announcements

DateSourceDetail
14 Feb, 2025NSE IndiaCaplin Point Laboratories Limited has informed the Exchange about Transcript
14 Feb, 2025BSE IndiaThe link for the transcript of the earnings call w.r.t financial performance of the company for quarter and nine months ended 31-12-2024 is enclosed.
08 Feb, 2025NSE IndiaCaplin Point Laboratories Limited has informed the Exchange about Copy of Newspaper Publication
07 Feb, 2025NSE IndiaCaplin Point Laboratories Limited has informed the Exchange about Link of Recording
07 Feb, 2025BSE IndiaThe web link for the audio recording of the Earnings call Q3 2024-25 held today i.e., Friday, February 02, 2025 at 17:00 hrs is enclosed
07 Feb, 2025NSE IndiaIntegrated Filing (Financial) for Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2024
07 Feb, 2025BSE IndiaIntegrated Filing (Financial) for Unaudited Financial Results for the quarter and nine months ended December 31, 2024 is enclosed
07 Feb, 2025NSE IndiaCaplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.
07 Feb, 2025NSE IndiaCaplin Point Laboratories Limited has informed the Exchange regarding Board meeting held on February 07, 2025.
07 Feb, 2025BSE IndiaFinancial Results along with the Limited Review Report, Press Release and Investor PPT for the Quarter Ended December 31, 2024 is enclosed

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--01 Feb, 202507 Feb, 2025
Quarterly Results--31 Oct, 202407 Nov, 2024
Quarterly Results & Final Dividend--01 Aug, 202407 Aug, 2024
Audited Results & Interim Dividend--10 May, 202416 May, 2024
Quarterly Results--31 Jan, 202409 Feb, 2024
Quarterly Results--02 Nov, 202309 Nov, 2023
Quarterly Results, Final Dividend & A.G.M.--02 Aug, 202307 Aug, 2023
Audited Results & Interim Dividend(Revised)24 May, 202327 May, 2023
Audited Results & Interim Dividend--24 May, 202324 May, 2023
Quarterly Results--31 Jan, 202311 Feb, 2023

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Sept, 2024Jun, 2024Mar, 2024Dec, 2023

About Caplin Point Laboratories

Caplin Point Laboratories is a Public Limited Listed company incorporated on 16/04/1990 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24231TN1990PLC019053 and registration number is 019053. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 625.09 Cr. and Equity Capital is Rs. 15.19 Cr. for the Year ended 31/03/2024.  Read More

Parent Organisation

Not Applicable

Founded

1990

Managing Director

Dr. Sridhar Ganesan

NSE Symbol

CAPLIPOINT

Caplin Point Laboratories Management

NameDesignation
Mr. C C PaarthipanChairman
Dr. Sridhar GanesanManaging Director
Dr. R NagendranIndependent Director
Mr. S DeenadayalanIndependent Director
Mr. D SathyanarayananIndependent Director
Dr. C K GariyaliIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
SunPhrmInds₹4,46,576.22₹1,643.75 image
₹1,669.30(-1.53%)
₹1,249.800 - ₹1,960.200
Divis Labora₹1,56,123.40₹5,757.05 image
₹5,978.30(-3.70%)
₹3,350.050 - ₹6,448.750
Cipla₹1,21,675.13₹1,475.75 image
₹1,479.70(-0.27%)
₹1,240.700 - ₹1,702.000
ManKind Phar₹1,18,478.90₹2,327.75 image
₹2,348.45(-0.88%)
₹1,910.100 - ₹3,050.000
DrReddysLab₹1,15,939.04₹1,151.80 image
₹1,170.95(-1.64%)
₹1,104.690 - ₹1,420.200

FAQs on Caplin Point Laboratories

What is the share price of Caplin Point Laboratories?

The share price of Caplin Point Laboratories on 21 Feb, 2025 is ₹ 2,022.90.

What is 52W high and 52W low share price of Caplin Point Laboratories?

The highest and lowest 52W share prices of Caplin Point Laboratories are ₹ 2636.000 and ₹ 1221.000

What is the market cap of Caplin Point Laboratories?

The market capitalization of Caplin Point Laboratories as of 21 Feb, 2025 is ₹ 15,429.23 Crores

What is the P/E ratio of Caplin Point Laboratories?

The current P/E ratio of Caplin Point Laboratories as of 21 Feb, 2025 is 43.99

What is the PB ratio of Caplin Point Laboratories?

The PB ratio of Caplin Point Laboratories as of 21 Feb, 2025 is 6.78

Top Gainers

948IHFL26I

IBHFL NCD186

₹845.00image

₹705.00 (0.20%)

GREAVESCOT

Greaves

₹281.85image

₹234.90 (0.20%)

ASHSI

Ashirwd Stl

₹45.66image

₹38.05 (0.20%)

CAPRO

Caprola.Chem

₹62.40image

₹52.00 (0.20%)

Top Losers

DHANBANK

Dhanalak.Bnk

₹32.19image

₹35.97 (-0.11%)

08MPD

08MPD

₹8.66image

₹9.62 (-0.10%)

BALTE

BalurghtTran

₹27.13image

₹31.24 (-0.13%)

DARSHANORNA

Darshan Orna

₹4.57image

₹5.07 (-0.10%)

Market Indices

Sensex

₹78,699.07image

₹78,472.48 (0.00%)

Source : Dion Global Solutions Limited